<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plospath</journal-id>
<journal-title-group>
<journal-title>PLOS Pathogens</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7366</issn>
<issn pub-type="epub">1553-7374</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.ppat.1006498</article-id>
<article-id pub-id-type="publisher-id">PPATHOGENS-D-16-00798</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral transmission and infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Major histocompatibility complex</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Major histocompatibility complex</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Major histocompatibility complex</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Major histocompatibility complex</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Major histocompatibility complex</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Experimental organism systems</subject><subj-group><subject>Model organisms</subject><subj-group><subject>Mouse models</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Model organisms</subject><subj-group><subject>Mouse models</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Experimental organism systems</subject><subj-group><subject>Animal models</subject><subj-group><subject>Mouse models</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Heredity</subject><subj-group><subject>Genetic mapping</subject><subj-group><subject>Haplotypes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Host genetics play a critical role in controlling CD8 T cell function and lethal immunopathology during chronic viral infection</article-title>
<alt-title alt-title-type="running-head">Host genetics contribute to CD8 T cell function</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5404-483X</contrib-id>
<name name-style="western">
<surname>Christiaansen</surname>
<given-names>Allison F.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Schmidt</surname>
<given-names>Megan E.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hartwig</surname>
<given-names>Stacey M.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Varga</surname>
<given-names>Steven M.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Microbiology, University of Iowa, Iowa City, IA, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Pathology, University of Iowa, Iowa City, IA, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Thomas</surname>
<given-names>Paul G.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>St. Jude Children's Research Hospital, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">steven-varga@uiowa.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>7</month>
<year>2017</year>
</pub-date>
<volume>13</volume>
<issue>7</issue>
<elocation-id>e1006498</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>6</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Christiaansen et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.ppat.1006498"/>
<abstract>
<p>Effective CD8 T cell responses are vital for the control of chronic viral infections. Many factors of the host immune response contribute to the maintenance of effector CD8 T cell responses versus CD8 T cell exhaustion during chronic infection. Specific MHC alleles and the degree of MHC heterogeneity are associated with enhanced CD8 T cell function and viral control during human chronic infection. However, it is currently unclear to what extent host genetics influences the establishment of chronic viral infection. In order to examine the impact of MHC heterogeneity versus non-MHC host genetics on the development of chronic viral infection, an F1 cross of B10.D2 x B6 (D2B6F1) and BALB.B x BALB/c (BCF1) mice were infected with the clone-13 (Cl-13) strain of lymphocytic choriomeningitis virus (LCMV). Following chronic Cl-13 infection both H-2<sup>bxd</sup> D2B6F1 and BCF1 mice demonstrated increased viral control compared to homozygous mice. Strikingly, H-2<sup>bxd</sup> D2B6F1 mice on a C57BL genetic background exhibited mortality following Cl-13 infection. CD8 T cell depletion prevented mortality in Cl-13-infected D2B6F1 mice indicating that mortality was CD8 T-cell-dependent. D2B6F1 mice maintained more CD8 T cell effector cytokine production and exhibited reduced expression of the T cell exhaustion marker PD-1. In addition, D2B6F1 mice also induced a larger Th1 response than BCF1 mice and Cl-13-induced mortality in D2B6F1 mice was also dependent on CD4 T-cell-mediated IFN-γ production. Thus, following a chronic viral infection, increased functionality of the CD8 T cell response allowed for more rapid viral clearance at the cost of enhanced immunopathology dependent on both MHC diversity and the genetic background of the host.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>Chronic viral infections pose a serious healthcare concern resulting in substantial mortality worldwide. Chronic viral infections result from the inability of the immune system to eliminate the virus from the infected individual. The immune system’s inability to eradicate the invading pathogen is partially due to excessive regulation of the T cell response. However, host genetics have been associated with enhanced T cell function and viral control during chronic infection. Therefore, we sought to investigate the role of host genetic diversity on the T cell response during chronic viral infection in a murine model. We found that increasing MHC heterogeneity resulted in an increased T cell response and enhanced viral control. In addition, host genetic background differences allowed for induction of a distinct CD4 T cell subset, which was associated with reduced suppression of the CD8 T cell response and enhanced viral control. Thus, specific features of the host genetic background contribute to the size and quality of the T cell response and resulting viral control. This study identifies components of the T cell response that may provide a therapeutic target to enhance T-cell-mediated viral control during chronic infection.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>T32 A1007533</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5404-483X</contrib-id>
<name name-style="western">
<surname>Christiaansen</surname>
<given-names>Allison F.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100008893</institution-id>
<institution>University of Iowa</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<name name-style="western">
<surname>Varga</surname>
<given-names>Steven M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution>American Association of Immunologists (US)</institution>
</funding-source>
<principal-award-recipient>
<name name-style="western">
<surname>Varga</surname>
<given-names>Steven M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>T32 AI007485</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Schmidt</surname>
<given-names>Megan E.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>Research reported in this publication was supported by the Department of Microbiology at the University of Iowa (to SMV), the American Association of Immunologist Careers in Immunology Fellowship (to SMV) and National Institutes of Health grants under award numbers T32A1007533 (to AFC) and T32AI007485 (to MES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="9"/>
<table-count count="0"/>
<page-count count="19"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2017-07-27</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Chronic viral infection such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV) affect an estimated 185 million people worldwide. In the course of these infections HIV and HCV are able to evade the host immune response and establish viral persistence. Genetic factors that influence the host T cell response have been shown to greatly impact viral load and disease progression [<xref ref-type="bibr" rid="ppat.1006498.ref001">1</xref>–<xref ref-type="bibr" rid="ppat.1006498.ref004">4</xref>]. Expression of either heterozygous human leukocyte antigen (HLA) class I alleles or the specific HLA alleles HLA B*5701 and HLA B*2701 are associated with enhanced CD8 T cell responses and reduced viral loads during HIV infection [<xref ref-type="bibr" rid="ppat.1006498.ref003">3</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref005">5</xref>–<xref ref-type="bibr" rid="ppat.1006498.ref008">8</xref>]. Clearance of HCV infection has also been associated with the expression of heterozygous HLA alleles as well as with the expression of specific HLA alleles [<xref ref-type="bibr" rid="ppat.1006498.ref002">2</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref004">4</xref>]. These host advantages driven by HLA expression patterns demonstrate the critical importance of the T cell response during chronic viral infection. In both humans and animal models of chronic viral infection, the capacity to maintain a functional CD8 T cell response has been shown to play a critical role in limiting viral replication [<xref ref-type="bibr" rid="ppat.1006498.ref009">9</xref>–<xref ref-type="bibr" rid="ppat.1006498.ref012">12</xref>]. However, constant CD8 T cell stimulation during chronic viral infection can drive CD8 T cells into a state of exhaustion where antiviral CD8 T cells progressively lose their effector functions, preventing effective clearance of infection [<xref ref-type="bibr" rid="ppat.1006498.ref013">13</xref>–<xref ref-type="bibr" rid="ppat.1006498.ref016">16</xref>]. CD8 T cell exhaustion is believed to occur in order to limit immunopathology to the host.</p>
<p>In addition to CD8 T cells, CD4 T cells also play a crucial role during the development of chronic viral infections. During HIV and murine infection with the persistent clone-13 (Cl-13) strain of lymphocytic choriomeningitis virus (LCMV), depletion of CD4 T cells is associated with reduced CD8 T cell effector functions and increased viral titers [<xref ref-type="bibr" rid="ppat.1006498.ref011">11</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref017">17</xref>]. Similar to CD8 T cells, CD4 T cell responses are altered by the presence of persistent antigen. Chronic viral infection drives CD4 T cell conversion from a Th1 phenotype critical for viral clearance to a T follicular helper (Tfh) phenotype [<xref ref-type="bibr" rid="ppat.1006498.ref018">18</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref019">19</xref>]. Thus, maintaining antiviral CD4 and CD8 T cell effector functions is vital to the control of chronic viral infection.</p>
<p>Murine models have often been used to delineate the contribution of MHC alleles versus host genetic background on mouse strain susceptibility to infection. BALB/c and C57BL/6 (B6) mice have been shown to differ in their susceptibility to infections in both MHC-dependent [<xref ref-type="bibr" rid="ppat.1006498.ref020">20</xref>–<xref ref-type="bibr" rid="ppat.1006498.ref022">22</xref>] and -independent manners [<xref ref-type="bibr" rid="ppat.1006498.ref023">23</xref>–<xref ref-type="bibr" rid="ppat.1006498.ref025">25</xref>]. However, the contribution of MHC alleles versus host genetic background has not been examined during chronic Cl-13 infection.</p>
<p>In the present study, we sought to determine the genetic influences on CD8 T cell exhaustion and the development of persistent viral infection using MHC congenic inbred and first generation (F1) crosses of various inbred mouse strains. Our results indicate that increasing MHC diversity allows for a broader CD8 T cell response that is able to more rapidly control persistent LCMV Cl-13 infection. However, F1 mice expressing a H-2<sup>bxd</sup> haplotype on different genetic backgrounds exhibit differences in both CD8 T cell exhaustion and CD4 T cell subset distribution, resulting in differences in viral control and disease. Unexpectedly, H-2<sup>bxd</sup> mice on a C57BL background succumb to LCMV Cl-13 infection in a T-cell- and IFN-γ-dependent manner. Thus, both MHC haplotype and genetic background together influence host resistance to CD8 T cell exhaustion and disease susceptibility following LCMV Cl-13 infection.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Host genetics influences viral persistence and Cl-13-induced mortality</title>
<p>Here we sought to determine the impact of host genetics on the course of a chronic LCMV Cl-13 infection. Mice expressing an H-2<sup>b</sup>, H-2<sup>d</sup> or H-2<sup>bxd</sup> haplotype on either a C57BL or BALB background were examined. MHC H-2<sup>bxd</sup> haplotype mice on the C57BL background were generated via an F1 cross of C57BL/6 and B10.D2 (D2B6F1) mice. Using a similar strategy H-2<sup>bxd</sup> haplotype mice on a BALB background were created via an F1 cross of BALB/c and BALB.B (BCF1) mice. To determine susceptibility to chronic infection, mice were infected with LCMV Cl-13 and disease and viral clearance were monitored. Whereas all strains developed weight loss following infection, only D2B6F1 mice exhibited mortality (<xref ref-type="fig" rid="ppat.1006498.g001">Fig 1A and 1B</xref>). D2B6F1 mice also displayed early control of viral replication and mice that survived exhibited enhanced viral clearance in both serum and systemic organs (<xref ref-type="fig" rid="ppat.1006498.g001">Fig 1C</xref>, upper panel and <xref ref-type="supplementary-material" rid="ppat.1006498.s001">S1 Fig</xref>). In addition, BCF1 mice exhibited enhanced viral clearance at day 30 post-infection as compared to MHC congenic mice on the same background (<xref ref-type="fig" rid="ppat.1006498.g001">Fig 1C</xref>, lower panel and <xref ref-type="supplementary-material" rid="ppat.1006498.s001">S1 Fig</xref>). Notably, viral tropism did not differ between mouse strains as determined by intracellular expression of the viral nucleoprotein (NP) in macrophages and various DC subsets in the spleen (<xref ref-type="supplementary-material" rid="ppat.1006498.s002">S2 Fig</xref>). These results indicate that H-2<sup>bxd</sup> haplotype mice mediate more rapid viral control than either of their H-2<sup>d</sup> or H-2<sup>b</sup> homozygous controls. However, on the C57BL genetic background, D2B6F1 mice control viral replication more rapidly but also succumb to infection, indicating a combined role for both MHC-linked genes and non-MHC background genes in the mortality resulting from LCMV Cl-13 infection.</p>
<fig id="ppat.1006498.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006498.g001</object-id>
<label>Fig 1</label>
<caption>
<title>H-2<sup>bxd</sup> mice on a C57BL background control virus but succumb to Cl-13 infection.</title>
<p>Mice were infected i.v. with LCMV Cl-13. (A) Weight loss and (B) survival were monitored following infection. (C) Viral titers were determined by plaque assay at the indicated time points in the serum following infection. Data depict cumulative data from 2–4 independent experiments <italic>(n</italic> = 7–18). Survival statistics were determined by Mantel-Cox Log-rank test. Titer differences were determined by t test at each time point. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec004">
<title>H-2<sup>bxd</sup> haplotype mice prioritize H-2<sup>d</sup>-restricted CD8 T cell responses over H-2<sup>b</sup>-restricted responses following acute LCMV infection</title>
<p>To determine the magnitude and epitope hierarchy of the CD8 T cell response induced in MHC H-2<sup>bxd</sup> haplotype mice under ideal T cell priming conditions, the CD8 T cell response was measured 8 days after an acute LCMV-Arm infection (<xref ref-type="fig" rid="ppat.1006498.g002">Fig 2</xref>, white bars). The total number and frequency of virus-specific CD8 T cells, as measured by expression of the surrogate activation marker CD11a and reduced expression of CD8, did not differ between heterozygous (F1) and homozygous MHC haplotype inbred control mice following acute LCMV infection (<xref ref-type="fig" rid="ppat.1006498.g002">Fig 2A</xref>). Further examination of epitope-specific responses revealed maintenance of both the immunodominant NP<sub>118</sub> and subdominant GP<sub>283</sub> H-2<sup>d</sup>-restricted responses in the MHC H-2<sup>bxd</sup> haplotype mice compared to homozygous MHC controls (<xref ref-type="fig" rid="ppat.1006498.g003">Fig 3A</xref>, <xref ref-type="supplementary-material" rid="ppat.1006498.s003">S3A Fig</xref>; white bars). However, within H-2<sup>b</sup>-restricted epitopes, responses to the immunodominant epitopes NP<sub>396</sub>, GP<sub>33</sub>, and GP<sub>276</sub> as well as the subdominant epitope NP<sub>205</sub> were significantly reduced in F1 mice compared to inbred controls (<xref ref-type="fig" rid="ppat.1006498.g003">Fig 3B</xref>, <xref ref-type="supplementary-material" rid="ppat.1006498.s003">S3B Fig</xref>; white bars). These data indicate that MHC H-2<sup>bxd</sup> haplotype mice induce a T cell response of similar magnitude as homozygous control mice by prioritizing H-2<sup>d</sup>-specific CD8 T cell responses over H-2<sup>b</sup>-specific responses following acute LCMV infection. Thus, following an acute LCMV infection NP<sub>118</sub> represents the immunodominant epitope and all of the H-2<sup>b</sup>-specific epitopes become subdominant.</p>
<fig id="ppat.1006498.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006498.g002</object-id>
<label>Fig 2</label>
<caption>
<title>D2B6F1 mice induce the largest frequency of activated CD8 T cells following Cl-13 infection.</title>
<p>Mice were infected with either LCMV Arm i.p. or Cl-13 i.v. and spleens were harvest 8 days later. The frequency (top) and total number (bottom) of CD11a<sup>hi</sup>CD8<sup>lo</sup> T cells are shown following (A) Arm and (B) Cl-13 infections. Data depict cumulative results from 3–4 independent experiments (<italic>n</italic> = 8–17). Statistics were determined by one-way ANOVA with Tukey’s multiple comparison test. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.g002" xlink:type="simple"/>
</fig>
<fig id="ppat.1006498.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006498.g003</object-id>
<label>Fig 3</label>
<caption>
<title>H-2<sup>bxd</sup> haplotype mice prioritize H-2<sup>d</sup>-restricted responses.</title>
<p>Mice were infected with either LCMV Arm i.p. or Cl-13 i.v. and spleens were harvest 8 days later. The frequency of tetramer-specific CD8 T cells were identified for (A) H-2<sup>d</sup>- and (B) H-2<sup>b</sup>- specific epitopes following Arm (left) and Cl-13 (right) infection. The fold change in the frequency of tetramer<sup>+</sup> from Cl-13 compared to Arm infection was examined for (C) H-2<sup>d</sup>- and (D) H-2<sup>b</sup>-specific epitopes. Data depict cumulative results from 3–4 independent experiments (<italic>n</italic> = 8–17). Statistics were determined by one-way ANOVA with Tukey’s multiple comparison test. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec005">
<title>D2B6F1 mice maintain the highest frequency of functional CD8 T cells during chronic viral infection</title>
<p>While the relative epitope-specific distribution within the virus-specific CD8 T cell response was altered in H-2<sup>bxd</sup> haplotype mice following acute infection, the magnitude of the overall virus-specific CD8 T cell response as determined by the number of CD11a<sup>hi</sup>CD8<sup>lo</sup> T cells was not altered (<xref ref-type="fig" rid="ppat.1006498.g002">Fig 2A</xref>). However, during chronic viral infection, D2B6F1 mice exhibited an increased frequency of CD11a<sup>hi</sup>CD8<sup>lo</sup> T cells (<xref ref-type="fig" rid="ppat.1006498.g002">Fig 2B</xref>). This indicates that a higher proportion of CD8 T cells were responding to Cl-13 infection in D2B6F1 mice than the inbred control mice.</p>
<p>Previous studies have shown that in B6 mice the immunodominace hierarchy is altered between LCMV Arm and Cl-13 infection [<xref ref-type="bibr" rid="ppat.1006498.ref013">13</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref026">26</xref>]. NP<sub>396</sub> represents the largest immunodominant epitope following Arm infection. However, NP<sub>396</sub>-specific CD8 T cells are the most rapid to exhaust and be deleted following Cl-13 infection [<xref ref-type="bibr" rid="ppat.1006498.ref013">13</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref026">26</xref>]. In contrast, the frequency of CD8 T cells specific to subdominant epitopes are maintained allowing for the emergence of subdominant epitope-specific CD8 T cells during chronic Cl-13 infection [<xref ref-type="bibr" rid="ppat.1006498.ref013">13</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref026">26</xref>]. Examination of individual CD8 T cell epitopes following chronic Cl-13 infection revealed that D2B6F1 mice either maintained or increased the frequency of CD8 T cells responding to many of the epitopes regardless of the proportion of CD8 T cells that responded during acute Arm infection (<xref ref-type="fig" rid="ppat.1006498.g003">Fig 3A and 3B</xref>; black bars). Moreover, both BCF1 and D2B6F1 mice maintained a higher proportion of antigen-specific CD8 T cells than inbred mice following chronic versus acute infection (<xref ref-type="fig" rid="ppat.1006498.g003">Fig 3C and 3D</xref>). In the F1 mice, a larger proportion of the H-2<sup>b</sup>-epitopes were expressed during chronic Cl-13 infection compared to during acute Arm infection, potentially due to their altered immunodominance hierarchy within the total CD8 T cell response (<xref ref-type="fig" rid="ppat.1006498.g003">Fig 3C and 3D</xref>). Thus, by broadening the number of epitopes recognized by the CD8 T cells in MHC heterozygous mice, we observe an increase in the total frequency of CD8 T cells responding based on CD11a<sup>hi</sup>CD8<sup>lo</sup> expression (<xref ref-type="fig" rid="ppat.1006498.g002">Fig 2B</xref>). Taken together, our results indicate that increasing MHC heterogeneity results in an increase in the frequency of responding CD8 T cells during a chronic viral infection.</p>
</sec>
<sec id="sec006">
<title>Impact of host genetic background on the effector functions of CD8 T cells during chronic infection</title>
<p>H-2<sup>bxd</sup>, D2B6F1 mice on the C57BL genetic background were the only strain tested that succumbed to Cl-13 infection (<xref ref-type="fig" rid="ppat.1006498.g001">Fig 1C</xref>). D2B6F1 mice also mounted a higher frequency CD8 T cell response than mice on the BALB/c background as determined by the frequency of cells that upregulate CD11a and downregulate CD8 (<xref ref-type="fig" rid="ppat.1006498.g002">Fig 2B</xref>). Previous studies have shown that CD8 T cell exhaustion early following Cl-13 infection prevents CD8 T-cell-induced mortality [<xref ref-type="bibr" rid="ppat.1006498.ref027">27</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref028">28</xref>]. An increase in the frequency of responding CD8 T cells in D2B6F1 mice suggests that CD8 T cells may play a role in mediating the Cl-13-induced mortality observed in this strain. Therefore, we sought to determine the functional capacity of the CD8 T cells and the degree of CD8 T cell exhaustion. Both H-2<sup>b</sup>- and H-2<sup>d</sup>-restricted CD8 T cell epitopes from D2B6F1 mice exhibited a greater frequency of IFN-γ and IFN-γ/TNF co-producing CD8 T cells than BCF1 mice following either Arm or Cl-13 infection (<xref ref-type="fig" rid="ppat.1006498.g004">Fig 4A and 4C</xref>; <xref ref-type="supplementary-material" rid="ppat.1006498.s004">S4 Fig</xref>). Interestingly, approximately ~70% of the CD8 T cell response in D2B6F1 mice is directed against NP<sub>118</sub>. In addition, the total number of NP<sub>118</sub>-specific CD8 T cells, representing the largest of the CD8 T cell epitopes, was significantly increased in D2B6F1 compared to BCF1 mice following Cl-13 infection (p &lt; 0.05; <xref ref-type="fig" rid="ppat.1006498.g004">Fig 4D</xref>). This result indicates that in addition to an increase in the frequency of responding CD8 T cells, D2B6F1 mice retain more functional virus-specific CD8 T cells than BCF1 mice. This further suggests a role for non-MHC host genetic background genes in the induction of the CD8 T cell response and the resulting Cl-13-induced mortality in D2B6F1 mice.</p>
<fig id="ppat.1006498.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006498.g004</object-id>
<label>Fig 4</label>
<caption>
<title>C57BL background H-2<sup>bxd</sup> mice exhibit increased CD8 T cell effector functions compared to BALB background mice.</title>
<p>Mice were infected with LCMV Cl-13 i.v and spleens were harvested 8 days later. (A) The frequency of IFN-γ<sup>+</sup> (y-axis) and TNF<sup>+</sup> (x-axis) CD90.2<sup>+</sup> CD8<sup>+</sup> T cells are shown following peptide stimulation. Geometric MFI (B), cumulative frequencies (C) and total numbers (D) of IFN-γ<sup>+</sup> CD8 T cells are shown. Data depict cumulative results from 3–4 independent experiments (<italic>n</italic> = 8–16). Statistics were determined by two-way ANOVA with Sidak’s multiple comparison test. *, <italic>p</italic> &lt; 0.05; ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec007">
<title>CD8 T cell exhaustion is influenced by the genetic background of the host</title>
<p>CD8 T cell exhaustion has been shown to occur in a stepwise fashion, where CD8 T cells initially lose the ability to produce TNF, followed by IFN-γ and eventually resulting in CD8 T cell deletion [<xref ref-type="bibr" rid="ppat.1006498.ref013">13</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref029">29</xref>]. In addition, exhausted CD8 T cells upregulate expression of multiple inhibitory receptors such as PD-1, CD160 and LAG-3 [<xref ref-type="bibr" rid="ppat.1006498.ref027">27</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref030">30</xref>]. To determine the extent of CD8 T cell exhaustion in D2B6F1 and BCF1 mice, we examined PD-1, CD160 and LAG-3 expression and epitope-specific IFN-γ production during Cl-13 infection. As early as day 8 post-infection, D2B6F1 mice exhibited reduced PD-1 and CD160 expression on their CD8 T cells (<xref ref-type="fig" rid="ppat.1006498.g005">Fig 5A</xref>). However, LAG-3 expression was similar between strains (<xref ref-type="fig" rid="ppat.1006498.g005">Fig 5A</xref>). By day 30 post-infection, virus was cleared from both LCMV Arm-infected mice and Cl-13-infected D2B6F1 mice and PD-1 and CD160 were no longer expressed on the CD8 T cells (<xref ref-type="fig" rid="ppat.1006498.g005">Fig 5B</xref>). However, Cl-13-infected BCF1 mice maintained high levels of virus and inhibitory ligand expression on their CD8 T cells at this time point (<xref ref-type="fig" rid="ppat.1006498.g005">Fig 5B</xref>). This difference in inhibitory ligand expression highlights a major difference between the MHC H-2<sup>bxd</sup> haplotype response on the C57BL and BALB background. At both day 8 (<xref ref-type="fig" rid="ppat.1006498.g005">Fig 5C</xref>) and day 30 (<xref ref-type="fig" rid="ppat.1006498.g005">Fig 5D</xref>) post-infection, D2B6F1 mice expressed a higher frequency of functional CD8 T cells than BCF1 mice. Thus, CD8 T cells from D2B6F1 mice exhibited reduced CD8 T cell exhaustion compared to their BCF1 counterparts. This increased CD8 T cell functionality may contribute to both the rapid viral control but also the Cl-13-mediated mortality observed in D2B6F1 mice.</p>
<fig id="ppat.1006498.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006498.g005</object-id>
<label>Fig 5</label>
<caption>
<title>C57BL background mice exhibit reduced CD8 T cell exhaustion compared to BALB background mice.</title>
<p>PD-1, CD160, and LAG-3 expression from day 8 (A) and day 30 (B) CD11a<sup>hi</sup>CD8<sup>lo</sup> T cells from Cl-13-infected BCF1 (dotted line), D2B6F1 (solid line), and Arm-infected (shaded) mice. The ratio of IFN-γ expressing CD8 T cells divided by the frequency of tetramer<sup>+</sup> CD8 T cells from day 8 (C) and day 30 (D) Cl-13-infected BCF1 (white) and D2B6F1 mice (black). Data depict cumulative results from 3–6 independent experiments (<italic>n</italic> = 6–22). Statistics were determined by two-way ANOVA with Sidak’s multiple comparison test. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; **, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec008">
<title>D2B6F1 mice exhibit an increased CD4 T cell response during chronic viral infection</title>
<p>CD4 T cells have been shown to play a vital role in limiting CD8 T cell exhaustion during chronic viral infection in B6 mice [<xref ref-type="bibr" rid="ppat.1006498.ref011">11</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref031">31</xref>]. To determine if the CD4 T cell response contributes to the reduced CD8 T cell exhaustion observed in D2B6F1 mice, we next examined the frequency and function of the virus-specific CD4 T cells. During LCMV Cl-13 infection, D2B6F1 mice exhibited a significantly increased frequency of antigen-specific CD4 T cells as measured by the surrogate activation markers CD11a and CD49d [<xref ref-type="bibr" rid="ppat.1006498.ref032">32</xref>], as compared to CD4 T cells from BCF1 mice (p&lt;0.0001; <xref ref-type="fig" rid="ppat.1006498.g006">Fig 6A</xref>). This increased frequency of virus-specific CD4 T cells coincides with a reduced expression of the exhaustion marker PD-1 on the responding CD4 T cells (<xref ref-type="fig" rid="ppat.1006498.g006">Fig 6B</xref>). D2B6F1 mice also exhibited an increased frequency of GP<sub>61</sub>-specific CD4 T cells by both IFN-γ production and GP<sub>66</sub> tetramer staining (<xref ref-type="fig" rid="ppat.1006498.g006">Fig 6C–6E</xref>). Our results indicate that expression of the MHC H-2<sup>bxd</sup> haplotype on the C57BL background results in the induction of a larger frequency of CD4 T cells following Cl-13 infection than is elicited in mice expressing the H-2<sup>bxd</sup> haplotype on the BALB background.</p>
<fig id="ppat.1006498.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006498.g006</object-id>
<label>Fig 6</label>
<caption>
<title>The C57BL background induces a robust CD4 T cell response during chronic viral infection.</title>
<p>Mice were infected with LCMV Cl-13 i.v and spleens were harvested 8 days later. (A) The frequency of CD11a<sup>hi</sup>CD49d<sup>+</sup> CD4 T cells following infection. (B) PD-1 expression in Cl-13-infected BCF1 (dotted line), D2B6F1 (solid line) mice and Arm-infected mice (filled line). (C) Flow plots and (D) cumulative data of IFN-γ<sup>+</sup> and TNF<sup>+</sup> cells following GP<sub>61</sub> peptide stimulation. (E) The frequency of GP<sub>66</sub>-tetramer<sup>+</sup> CD4 T cells. Data depict cumulative results from 3–5 independent experiments (<italic>n</italic> = 12–21). Statistics were determined by <italic>t</italic> test. ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.g006" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec009">
<title>H-2<sup>bxd</sup> haplotype mice on the C57BL genetic background maintain Th1-polarized CD4 T cells during chronic viral infection</title>
<p>Following a chronic Cl-13 infection, CD4 T cells have been shown to convert from Th1 to a Tfh phenotype [<xref ref-type="bibr" rid="ppat.1006498.ref018">18</xref>]. In an acute LCMV Arm infection, the Th1 cells are maintained and IFN-γ production has been shown to play a pivotal role in supporting CD8 T cell effector activity [<xref ref-type="bibr" rid="ppat.1006498.ref018">18</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref033">33</xref>]. Furthermore, Th1 cells contribute to viral clearance during an acute infection [<xref ref-type="bibr" rid="ppat.1006498.ref034">34</xref>]. In a chronic infection, IL-21 production by Tfh cells has been shown to be the primary mechanism by which CD4 T cells help maintain CD8 T cell effector functions at late stages of infection [<xref ref-type="bibr" rid="ppat.1006498.ref018">18</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref035">35</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref036">36</xref>]. Here we find that D2B6F1 mice, which exhibit reduced CD8 T cell exhaustion and more rapid viral clearance, maintain a higher proportion of Th1 (Tbet<sup>+</sup> CD4<sup>+</sup>) cells while BCF1 mice exhibit more Tfh (CXCR5<sup>+</sup> CD4<sup>+</sup>) cells (<xref ref-type="fig" rid="ppat.1006498.g007">Fig 7</xref>). Thus, our results indicate that maintaining Th1-biased CD4 T cell responses may prevent CD8 T cell exhaustion and viral persistence early during Cl-13 infection allowing for more rapid viral control.</p>
<fig id="ppat.1006498.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006498.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Cl-13 infection of mice on a C57BL background results in an enhanced Th1 response.</title>
<p>Mice were infected with LCMV Cl-13 i.v and spleens were harvested 8 days post-infection. (A) Flow plots depicting Tbet and CXCR5 expression on CD4 T cells 8 days post-infection. (B) Cumulative frequencies of CXCR5 and Tbet expressing CD4 T cells following Cl-13 infection. (C) Pie charts depict the proportions of CXCR5 and Tbet expressing CD4 T cells following Cl-13 infection. Data depict cumulative results from 3–5 independent experiments (<italic>n</italic> = 5–21). Statistics were determined by two-way ANOVA with Sidak’s multiple comparison test. ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.g007" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec010">
<title>CD8 and CD4 T cells contribute to Cl-13-induced mortality in D2B6F1 mice</title>
<p>CD8 T cell exhaustion occurs in order to prevent CD8 T-cell-mediated immunopathology [<xref ref-type="bibr" rid="ppat.1006498.ref027">27</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref028">28</xref>]. In the absence of inhibitory receptors during the early stages of chronic viral infection, CD8 T cells have been shown to both clear virus and induce lethal immunopathology [<xref ref-type="bibr" rid="ppat.1006498.ref027">27</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref028">28</xref>]. During LCMV Cl-13 infection, CD4 T cells provide vital help for CD8 T-cell-mediated viral control [<xref ref-type="bibr" rid="ppat.1006498.ref011">11</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref031">31</xref>]. To determine if the increased effector functions observed for both CD8 and CD4 T cells in D2B6F1 mice contributes to their mortality, we depleted CD8 and CD4 T cells prior to Cl-13 infection. In the absence of either CD4 or CD8 T cells, D2B6F1 mice survived Cl-13 infection (<xref ref-type="fig" rid="ppat.1006498.g008">Fig 8A and 8B</xref>). In addition, CD8 T cell depletion did not alter the frequency of the CD4 T cell response, indicating that CD4 T cells alone cannot induce mortality in the absence of CD8 T cells (<xref ref-type="fig" rid="ppat.1006498.g008">Fig 8D</xref>). In contrast, CD4 T cell depletion resulted in a significant reduction in the frequency of activated and epitope-specific CD8 T cells (<xref ref-type="fig" rid="ppat.1006498.g008">Fig 8E</xref>). This indicates that CD4 depletion may enhance the survival of D2B6F1 mice by affecting the magnitude of the CD8 T cell response. Furthermore, CD8 and/or CD4 T cell depletion resulted in increased viral titers, confirming their critical role in the enhanced viral control observed in D2B6F1 mice (<xref ref-type="fig" rid="ppat.1006498.g008">Fig 8C</xref>). These results indicate that the increased CD8 T cell response observed in D2B6F1 mice results in both enhanced viral control and mortality in D2B6F1 mice.</p>
<fig id="ppat.1006498.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006498.g008</object-id>
<label>Fig 8</label>
<caption>
<title>Both CD4 and CD8 T cells contribute to Cl-13-induced mortality in D2B6F1 mice.</title>
<p>D2B6F1 mice were treated with 200 μg IgG, anti-CD4, anti-CD8 or both on day -2, 2, 6, 10 following LCMV Cl-13 infection. (A) Survival (survived/infected) and (B) weight loss were monitored following infection. (C) Serum viral titers were determined on day 10 post-infection. (D) The frequency of CD11a<sup>hi</sup>CD49<sup>+</sup> and GP<sub>61</sub>-peptide specific CD4 T cells following stimulation were assessed on day 8 post-infection in the PBL. (E) The frequency of CD11a<sup>hi</sup>CD8<sup>lo</sup> and peptide-specific CD8 T cells following stimulation were assessed on day 8 post-infection in the PBL. Data depict cumulative results from 2 independent experiments (<italic>n</italic> = 5–9). Statistics were determined by <italic>t</italic> test, one-way ANOVA with Tukey’s post-test, or two-way ANOVA with Sidak’s multiple comparison test. Survival statistics were determined by log rank Mantel-Cox test compared to IgG treated mice. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.g008" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec011">
<title>IFN-γ contributes to mortality and viral control in D2B6F1 mice</title>
<p>To determine the role of Th1-associated cytokines on Cl-13-induced mortality in D2B6F1 mice, IFN-γ was depleted prior to infection. IFN-γ is produced by both CD8 and CD4 T cells during chronic viral infection and has been shown to contribute to viral clearance and immunopathology [<xref ref-type="bibr" rid="ppat.1006498.ref037">37</xref>–<xref ref-type="bibr" rid="ppat.1006498.ref039">39</xref>]. Depletion of CD4 T cells, but not CD8 T cells, resulted in a significant decrease in the amount of IFN-γ protein in the serum during Cl-13 infection (p&lt;0.001; <xref ref-type="fig" rid="ppat.1006498.g009">Fig 9A</xref>). In addition, IFN-γ neutralization reduced the magnitude of both the CD4 and CD8 T cell response in D2B6F1 mice (<xref ref-type="fig" rid="ppat.1006498.g009">Fig 9B and 9C</xref>). Importantly, IFN-γ neutralization resulted in increased survival (<xref ref-type="fig" rid="ppat.1006498.g009">Fig 9D</xref>). Furthermore, IFN-γ neutralization resulted in increased viral titers in the serum (<xref ref-type="fig" rid="ppat.1006498.g009">Fig 9E</xref>). These results indicate that CD4 T-cell-mediated IFN-γ production plays a critical role in CD8 T cell induction, viral control and the mortality observed in D2B6F1 mice during Cl-13 infection.</p>
<fig id="ppat.1006498.g009" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006498.g009</object-id>
<label>Fig 9</label>
<caption>
<title>IFN-γ contributes to mortality and viral control following Cl-13 infection in D2B6F1 mice.</title>
<p>(A) D2B6F1 mice were treated with 200 μg IgG, anti-CD4, anti-CD8 or both on day -2, and 2 following LCMV Cl-13 infection and serum was collected on day 6 for IFN-γ ELISA. In the remaining panels D2B6F1 mice were treated with 200 μg IgG or anti-IFN-γ on day -1, 1, 3, 5, 7, and 9 days post-Cl-13 infection. The frequency of activated CD4 (B) and CD8 (C) T cells were analyzed on day 8 post-infection. (D) Survival (survived/infected) was monitored following infection. (E) Serum viral titers were measured on day 10 post-infection. Data depict cumulative results from 2–5 independent experiments (<italic>n</italic> = 7–30). Survival statistics were determined by log rank Mantel-Cox test compared to IgG treated mice. One-way ANOVA and Tukey’s post-test were used to determined titer statistics. **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.g009" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec012" sec-type="conclusions">
<title>Discussion</title>
<p>Host susceptibility to the establishment of a persistent viral infection is linked to the ability of the host to mount an effective CD8 T cell response to control virus replication. However, CD8 T-cell-mediated viral control is limited by T cell exhaustion during chronic infection, which occurs to prevent T-cell-mediated pathology [<xref ref-type="bibr" rid="ppat.1006498.ref028">28</xref>]. Thus, understanding the mechanisms that induce an effective CD8 T cell response to prevent viral persistence without the induction of immunopathology is vital to the prevention of chronic infection. Here we show both MHC heterogeneity and host genetic background significantly impact CD8 T cell exhaustion and viral clearance.</p>
<p>CD8 T cells are important for clearing acute LCMV Arm infection and help to maintain viral control during chronic LCMV Cl-13 infection [<xref ref-type="bibr" rid="ppat.1006498.ref011">11</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref040">40</xref>]. Increasing the diversity of viral antigens presented during chronic viral infection often increases viral control [<xref ref-type="bibr" rid="ppat.1006498.ref002">2</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref005">5</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref006">6</xref>]. We show that both D2B6F1 mice and BCF1 mice induce an increased frequency of activated CD8 T cells compared to their inbred controls resulting in enhanced viral control. This is similar to the enhanced viral control observed in HLA heterozygote individuals during both HCV and HIV infection [<xref ref-type="bibr" rid="ppat.1006498.ref002">2</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref006">6</xref>]. In addition, D2B6F1 mice induce both a larger CD8 T cell response and maintain increased effector functions compared to BCF1 mice. Similar to CD8 T cell depletion during SIV infection of macaques [<xref ref-type="bibr" rid="ppat.1006498.ref041">41</xref>], CD8 T cell depletion in D2B6F1 mice ameliorates the enhanced viral control observed during Cl-13 infection. Thus, individuals that induce a CD8 T cell response that recognizes a broader range of epitopes are more capable of controlling and clearing chronic viral infections.</p>
<p>Increasing CD8 T cell function is desired for enhanced control and clearance of chronic viral infection. However, the purpose of CD8 T cell exhaustion is to prevent CD8 T-cell-mediated immunopathology. Previous studies have shown that PD-1 deficiency early during infection results in CD8 T-cell-mediated mortality [<xref ref-type="bibr" rid="ppat.1006498.ref027">27</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref028">28</xref>]. This is due to an increase in CD8 T cell numbers and function in PD-1-deficient mice (22, 23). Similarly, we observe the mortality in D2B6F1 mice is associated with an increased CD8 T cell response and reduced CD8 T cell exhaustion. In the absence of PD-1, mice succumb to chronic infection due to perforin-mediated killing of endothelial cells by CD8 T cells resulting in increased vascular permeability [<xref ref-type="bibr" rid="ppat.1006498.ref028">28</xref>]. However, D2B6F1 mice do exhibit low levels of PD-1 expression potentially resulting in a less severe and delayed mortality compared to PD-1-deficient mice.</p>
<p>Increasing MHC diversity resulted in CD8 T-cell-mediated mortality that was dependent on the host genetic background. Increasing MHC diversity allows for induction of a broader CD8 T cell response. However, during chronic viral infection T cell exhaustion limits the size and function of the virus-specific T cell response [<xref ref-type="bibr" rid="ppat.1006498.ref013">13</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref029">29</xref>]. Our results indicate that the genetic background of the host influences the extent of CD8 T cell exhaustion. CD4 T cells play an important role in CD8 T cell exhaustion [<xref ref-type="bibr" rid="ppat.1006498.ref011">11</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref031">31</xref>] and mouse strain susceptibility to infection often differs based on their ability to mount an appropriate CD4 T cell response [<xref ref-type="bibr" rid="ppat.1006498.ref024">24</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref042">42</xref>–<xref ref-type="bibr" rid="ppat.1006498.ref044">44</xref>]. During acute infection, a Th1-biased response is induced to aid in rapid viral clearance [<xref ref-type="bibr" rid="ppat.1006498.ref024">24</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref034">34</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref042">42</xref>–<xref ref-type="bibr" rid="ppat.1006498.ref045">45</xref>]. However, BALB/c mice often induce weaker Th1 responses than B6 mice [<xref ref-type="bibr" rid="ppat.1006498.ref042">42</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref043">43</xref>]. For example, BALB/c mice are more susceptible to <italic>Leishmania</italic> and RSV infections due to their inability to mount robust Th1 responses [<xref ref-type="bibr" rid="ppat.1006498.ref023">23</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref024">24</xref>, <xref ref-type="bibr" rid="ppat.1006498.ref043">43</xref>]. Thus, B6 mice are able to more easily clear Th1-dependent pathogens [<xref ref-type="bibr" rid="ppat.1006498.ref042">42</xref>]. In addition, perforin-deficient mice succumb to acute LCMV Arm infection in a IFN-γ-dependent manner [<xref ref-type="bibr" rid="ppat.1006498.ref046">46</xref>]. However, this effect is only observed in B6 mice, not BALB/c mice [<xref ref-type="bibr" rid="ppat.1006498.ref047">47</xref>]. This difference is believed to be due to a weaker IFN-γ response in BALB/c mice, and only when memory CD8 cells are generated prior to LCMV infection do perforin-deficient BALB/c mice succumb to IFN-γ-mediated death [<xref ref-type="bibr" rid="ppat.1006498.ref047">47</xref>]. While both BALB/c and B6 mice are susceptible to persistent viral infection, only H-2<sup>bxd</sup> expressing mice on the C57BL background succumb to Cl-13 infection. This is not due to differences in viral tropism between mouse strains as determined by intracellular expression of the LCMV NP protein in macrophages and various dendritic cell subsets. The mortality exhibited by the D2B6F1 mice may be due to the relative distribution of CD4 Th subsets. At the peak of the T cell response, D2B6F1 mice were found to induce a larger Th1 response than BCF1 mice. This increased Th1 response in D2B6F1 mice may help to mediate the larger and more functional CD8 T cell response observed in D2B6F1 mice versus BCF1 mice. Thus, D2B6F1 mice exhibit the combined effect of enhanced CD4 T cell help due to increased Th1 polarization and reduced viral load and antigen as a result of a broader T cell response because of the increase in MHC heterogeneity resulting in reduced CD8 T cell exhaustion as compared to the other mouse strains examined. Therefore, both the immune environment and the increased MHC diversity contribute to the CD8 T-cell-dependent viral clearance and mortality observed in D2B6F1 mice.</p>
<p>The majority of studies examining CD8 T cell exhaustion following LCMV Cl-13 infection are conducted in inbred B6 mice. However, our findings demonstrate that the host genetic background can profoundly influence the outcome of an LCMV Cl-13 infection. Thus, utilization of hosts with more diverse genetic backgrounds are likely to yield additional factors involved in CD8 T cell exhaustion and the establishment of chronic infections opening new potential avenues for therapeutic interventions to prevent chronic infection in humans.</p>
</sec>
<sec id="sec013" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec014">
<title>Mice and infection</title>
<p>BALB/c and C57BL/6 mice were purchased from National Cancer Institute (Fredrick, MD) and bred in the University of Iowa animal facility. BALB.B and B10.D2 mice were purchased from the Jackson Laboratory (Fredrick, MD) and bred in the University of Iowa animal facility. First generation BALB.B x BALB/c (BCF1) mice and B10.D2 x C57BL/6 (D2B6F1) mice were created in the University of Iowa animal facility. All mice were utilized between 6–8 weeks of age. The Arm and Cl-13 strains of LCMV were gifts from Dr. Raymond Welsh (University of Massachusetts Medical School, Worcester, MA) and propagated in BHK-21 cells (ATCC). For LCMV Arm infection, mice were infected i.p. with 2 x 10<sup>5</sup> PFU. For LCMV Cl-13 infection, mice were infected i.v. with 1.8 x 10<sup>6</sup> PFU. Disease was assessed daily by monitoring weight loss and survival.</p>
</sec>
<sec id="sec015">
<title>Ethics statement</title>
<p>All experimental procedures utilizing mice were approved by the University of Iowa Animal Care and Use Committee. The experiments were performed under strict accordance to the Office of Laboratory Animal Welfare guidelines and the PHS Policy on Humane Care and Use of Laboratory Animals.</p>
</sec>
<sec id="sec016">
<title>Plaque assays</title>
<p>Serum, lung, liver, and kidneys were harvested from Cl-13-infected mice. Serum was isolated from whole blood collected in heparinized tubes (Fisher; Pittsburgh, PA), capped (Lecia Microsystems; Richmond, IL) and spun at 2500 rpm for 30 min. Serum was collected and snap-frozen in liquid nitrogen prior to storage at -80°C. Lung, liver and kidneys were homogenized and processed for plaque assays as previously described [<xref ref-type="bibr" rid="ppat.1006498.ref048">48</xref>].</p>
</sec>
<sec id="sec017">
<title>Antibody depletion</title>
<p>For T cell depletion, mice were administered 200 μg of rat IgG (MP Biomedicals, Aurora, OH) or anti-CD4 (clone GK1.5) and/or anti-CD8 (clone 2.43) i.p. on days -2, 2, 6, 10 relative to infection. Depletion was verified in the blood on day 6 post-infection. For cytokine depletion, mice were administered 200 μg of rat IgG (MP Biomedicals), anti-IFN-γ (clone XMG1.2), or anti-TNF (clone XT22) i.p. on days -1, 1, 3, 5, 7, and 9 relative to infection.</p>
</sec>
<sec id="sec018">
<title>Flow cytometry analysis</title>
<p>Cells were isolated from the blood and spleen as previously described [<xref ref-type="bibr" rid="ppat.1006498.ref048">48</xref>]. For detection of antigen-specific cytokine responses cells were stimulated with 1μM NP<sub>396-404</sub>, GP<sub>33-41</sub>, GP<sub>276-286</sub>, NP<sub>118-126</sub>, GP<sub>283-291</sub>, or GP<sub>61-80</sub> (Biosynthesis, Lewisville, TX) in the presence of 10 μg/ml BFA (Sigma Aldrich) for 5 hour at 37°C in 10% FCS-supplemented RPMI. For tetramer staining, cells were incubated with a single tetramer (NP<sub>118-126</sub>, GP<sub>283-291</sub>, GP<sub>66-77</sub>, and NP<sub>205-212</sub> from NIH Tetramer Core Facility; NP<sub>396-404</sub>, GP<sub>33-41</sub>, and GP<sub>276-286</sub> made in house) for 30 min at 4°C for CD8 tetramers or 90 min at 37°C for the CD4 tetramer. Following tetramer staining or stimulation, cells were fixed using 1-step Fix/Lyse Solution (eBioscience, San Diego, CA). For staining of transcription factors, cells were fixed with Foxp3 staining buffer set (eBioscience) and stained intracellularly for Tbet (clone 4B10). Cells were stained with the extracellular mAbs specific to CD90.2 (clone 53–2.1), CD8α (clone 53–6.7), CD4 (clone RM4-5), CD11a (clone M17/4), CD49d (clone R1-2), and PD-1 (clone RMP1-30, all previous antibodies from eBioscience and Biolegend) for 15 min at 4°C. For CXCR5 staining, cells were stained with the mAb for CXCR5 (biotin, BD Pharmingen) at room temperature for 30 min followed by streptavidin-PE (eBioscience) in FACS buffer. Cells were stained for the intracellular mAbs specific to IFN-γ (XMG1.2), TNF (clone MP6-XT22) in FACS Buffer containing 0.5% saponin (Sigma-Aldrich) for 30 min at 4°C. Intracellular staining for LCMV NP using a directly PE-conjugated Rat anti-LCMV NP mAb clone VL-4 [<xref ref-type="bibr" rid="ppat.1006498.ref049">49</xref>] (a gift from Dirk Homann, Icahn School of Medicine at Mount Sinai, New York, NY) was performed as previously described [<xref ref-type="bibr" rid="ppat.1006498.ref050">50</xref>]. Samples were run on a BD LSRFortessa flow cytometer and data was analyzed using FlowJo software (Tree Star Inc, Ashland, OR).</p>
</sec>
<sec id="sec019">
<title>Statistical analysis</title>
<p>Graphical and statistical analyses were performed using Prism software (GraphPad Software Inc., San Diego, CA) with error bars representing the SEM. <italic>P</italic> values were considered significant when <italic>p</italic>&lt;0.05.</p>
</sec>
</sec>
<sec id="sec020">
<title>Supporting information</title>
<supplementary-material id="ppat.1006498.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>H-2<sup>bxd</sup> mice control chronic viral infection more rapidly than inbred mice.</title>
<p>Mice were infected i.v. with LCMV Cl-13 and viral titers were determined by plaque assay at day 30 following infection. Data depict cumulative results from 4 independent experiments (<italic>n</italic> = 3–15). Titer differences were determined by one-way ANOVA with Tukey’s post-test. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006498.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Viral tropism does not vary between mouse backgrounds.</title>
<p>Mice were infected i.v. with LCMV Cl-13 and viral tropism was determined by the frequency (A, C) and total number (B, D) of NP<sup>+</sup> DCs and Macrophages on day 8 post-infection. All cell populations were negative for expression CD3, CD19, and DX5 and positive for CD45. cDCs were also gated on CD11c<sup>+</sup> F4/80<sup>-</sup>. pDCs were gated on CD11c<sup>+</sup> F4/80<sup>-</sup> B220<sup>+</sup>. Macrophages were F4/80<sup>+</sup>. Statistics were determined by two-way ANOVA with Sidak’s multiple comparison test.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006498.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>The total numbers of Tet-specific CD8 T cells.</title>
<p>Mice were infected with either LCMV Arm i.p. or Cl-13 i.v. and spleens were harvest 8 days later. The total number of tetramer-specific CD8 T cells were identified for (A) H-2<sup>d</sup>- and (B) H-2<sup>b</sup>- specific epitopes following Arm (left) and Cl-13 (right) infection. Data depict cumulative results from 3–4 independent experiments (<italic>n</italic> = 8–17). Statistics were determined by one-way ANOVA with Tukey’s multiple comparison test. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006498.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006498.s004" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>CD8 T cell cytokine production is impaired following Cl-13 infection compared to Arm infection.</title>
<p>Mice were infected with either LCMV Arm i.p. or Cl-13 i.v. and spleens were harvest 8 days later. Flow plots depicting cytokine producing CD8 T cells following NP118 (A) or NP396 (B) stimulation are shown. Cumulative frequencies are shown for IFN-γ<sup>+</sup>TNF<sup>+</sup> CD8 T cells following Arm (C) and Cl-13 (D) infection. Data depict cumulative results from 3–4 independent experiments (<italic>n</italic> = 8–17). Statistics were determined by two-way ANOVA with Sidak’s multiple comparison test. *, <italic>p</italic> &lt; 0.05; ***, <italic>p</italic> &lt; 0.001.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="ppat.1006498.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brackin</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Lewis</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Brackin</surname> <given-names>BT</given-names></name>, <name name-style="western"><surname>Achord</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Henderson</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Crawford</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Progression of HIV infection is associated with HLA-DQ antigens in Caucasians and African Americans</article-title>. <source>Pathobiology</source>. <year>1995</year>;<volume>63</volume>(<issue>1</issue>):<fpage>22</fpage>–<lpage>41</lpage>. Epub 1995/01/01. <object-id pub-id-type="pmid">7546273</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hraber</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Kuiken</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Yusim</surname> <given-names>K</given-names></name>. <article-title>Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection</article-title>. <source>Hepatology</source>. <year>2007</year>;<volume>46</volume>(<issue>6</issue>):<fpage>1713</fpage>–<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/hep.21889" xlink:type="simple">10.1002/hep.21889</ext-link></comment> <object-id pub-id-type="pmid">17935228</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaslow</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Carrington</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Apple</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Munoz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Saah</surname> <given-names>AJ</given-names></name>, <etal>et al</etal>. <article-title>Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection</article-title>. <source>Nat Med</source>. <year>1996</year>;<volume>2</volume>(<issue>4</issue>):<fpage>405</fpage>–<lpage>11</lpage>. Epub 1996/04/01. <object-id pub-id-type="pmid">8597949</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McKiernan</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Hagan</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Curry</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>McDonald</surname> <given-names>GSA</given-names></name>, <name name-style="western"><surname>Kelly</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nolan</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source</article-title>. <source>Hepatology</source>. <year>2004</year>;<volume>40</volume>(<issue>1</issue>):<fpage>108</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/hep.20261" xlink:type="simple">10.1002/hep.20261</ext-link></comment> <object-id pub-id-type="pmid">15239092</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trachtenberg</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Korber</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Sollars</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kepler</surname> <given-names>TB</given-names></name>, <name name-style="western"><surname>Hraber</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Hayes</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Advantage of rare HLA supertype in HIV disease progression</article-title>. <source>Nat Med</source>. <year>2003</year>;<volume>9</volume>(<issue>7</issue>):<fpage>928</fpage>–<lpage>35</lpage>. Epub 2003/06/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm893" xlink:type="simple">10.1038/nm893</ext-link></comment> <object-id pub-id-type="pmid">12819779</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carrington</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nelson</surname> <given-names>GW</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Kissner</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Vlahov</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Goedert</surname> <given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage</article-title>. <source>Science</source>. <year>1999</year>;<volume>283</volume>(<issue>5408</issue>):<fpage>1748</fpage>–<lpage>52</lpage>. Epub 1999/03/12. <object-id pub-id-type="pmid">10073943</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Almeida</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Price</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Papagno</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Arkoub</surname> <given-names>ZA</given-names></name>, <name name-style="western"><surname>Sauce</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Bornstein</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover</article-title>. <source>J Exp Med</source>. <year>2007</year>;<volume>204</volume>(<issue>10</issue>):<fpage>2473</fpage>–<lpage>85</lpage>. Epub 2007/09/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20070784" xlink:type="simple">10.1084/jem.20070784</ext-link></comment> <object-id pub-id-type="pmid">17893201</object-id>; PubMed Central PMCID: PMCPMC2118466.</mixed-citation></ref>
<ref id="ppat.1006498.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Altfeld</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Addo</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Rosenberg</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Hecht</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>PK</given-names></name>, <name name-style="western"><surname>Vogel</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection</article-title>. <source>AIDS (London, England)</source>. <year>2003</year>;<volume>17</volume>(<issue>18</issue>):<fpage>2581</fpage>–<lpage>91</lpage>. Epub 2003/12/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/01.aids.0000096870.36052.b6" xlink:type="simple">10.1097/01.aids.0000096870.36052.b6</ext-link></comment> <object-id pub-id-type="pmid">14685052</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Betts</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Nason</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>West</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>De Rosa</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Migueles</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Abraham</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells</article-title>. <source>Blood</source>. <year>2006</year>;<volume>107</volume>(<issue>12</issue>):<fpage>4781</fpage>–<lpage>9</lpage>. Epub 2006/02/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1182/blood-2005-12-4818" xlink:type="simple">10.1182/blood-2005-12-4818</ext-link></comment> <object-id pub-id-type="pmid">16467198</object-id>; PubMed Central PMCID: PMCPMC1895811.</mixed-citation></ref>
<ref id="ppat.1006498.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jin</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Bauer</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Tuttleton</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Lewin</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gettie</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Blanchard</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus–infected macaques</article-title>. <source>J Exp Med</source>. <year>1999</year>;<volume>189</volume>(<issue>6</issue>):<fpage>991</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.189.6.991" xlink:type="simple">10.1084/jem.189.6.991</ext-link></comment> <object-id pub-id-type="pmid">10075982</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matloubian</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Concepcion</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Ahmed</surname> <given-names>R</given-names></name>. <article-title>CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection</article-title>. <source>J Virol</source>. <year>1994</year>;<volume>68</volume>(<issue>12</issue>):<fpage>8056</fpage>–<lpage>63</lpage>. <object-id pub-id-type="pmid">7966595</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schmitz</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Kuroda</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Santra</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sasseville</surname> <given-names>VG</given-names></name>, <name name-style="western"><surname>Simon</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Lifton</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes</article-title>. <source>Science</source>. <year>1999</year>;<volume>283</volume>(<issue>5403</issue>):<fpage>857</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.283.5403.857" xlink:type="simple">10.1126/science.283.5403.857</ext-link></comment> <object-id pub-id-type="pmid">9933172</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wherry</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Blattman</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Murali-Krishna</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>van der Most</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ahmed</surname> <given-names>R</given-names></name>. <article-title>Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment</article-title>. <source>J Virol</source>. <year>2003</year>;<volume>77</volume>(<issue>8</issue>):<fpage>4911</fpage>–<lpage>27</lpage>. Epub 2003/03/29. PubMed Central PMCID: PMCPmc152117. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.77.8.4911-4927.2003" xlink:type="simple">10.1128/JVI.77.8.4911-4927.2003</ext-link></comment> <object-id pub-id-type="pmid">12663797</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gruener</surname> <given-names>NH</given-names></name>, <name name-style="western"><surname>Lechner</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Jung</surname> <given-names>M-C</given-names></name>, <name name-style="western"><surname>Diepolder</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Gerlach</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Lauer</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus</article-title>. <source>J Virol</source>. <year>2001</year>;<volume>75</volume>(<issue>12</issue>):<fpage>5550</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.75.12.5550-5558.2001" xlink:type="simple">10.1128/JVI.75.12.5550-5558.2001</ext-link></comment> <object-id pub-id-type="pmid">11356962</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khaitan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Unutmaz</surname> <given-names>D</given-names></name>. <article-title>Revisiting immune exhaustion during HIV infection</article-title>. <source>Current HIV/AIDS reports</source>. <year>2011</year>;<volume>8</volume>(<issue>1</issue>):<fpage>4</fpage>–<lpage>11</lpage>. Epub 2010/12/29. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11904-010-0066-0" xlink:type="simple">10.1007/s11904-010-0066-0</ext-link></comment> <object-id pub-id-type="pmid">21188556</object-id>; PubMed Central PMCID: PMCPmc3144861.</mixed-citation></ref>
<ref id="ppat.1006498.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ye</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Kong</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Tian</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>. <article-title>T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance</article-title>. <source>Cell Death Dis</source>. <year>2015</year>;<volume>6</volume>:<fpage>e1694</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cddis.2015.42" xlink:type="simple">10.1038/cddis.2015.42</ext-link></comment> <object-id pub-id-type="pmid">25789969</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosenberg</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Billingsley</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Caliendo</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Boswell</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Sax</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Kalams</surname> <given-names>SA</given-names></name>, <etal>et al</etal>. <article-title>Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia</article-title>. <source>Science</source>. <year>1997</year>;<volume>278</volume>(<issue>5342</issue>):<fpage>1447</fpage>–<lpage>50</lpage>. Epub 1997/12/31. <object-id pub-id-type="pmid">9367954</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fahey</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>EB</given-names></name>, <name name-style="western"><surname>Elsaesser</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Fistonich</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>McGavern</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Brooks</surname> <given-names>DG</given-names></name>. <article-title>Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells</article-title>. <source>J Exp Med</source>. <year>2011</year>;<volume>208</volume>(<issue>5</issue>):<fpage>987</fpage>–<lpage>99</lpage>. Epub 2011/05/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20101773" xlink:type="simple">10.1084/jem.20101773</ext-link></comment> <object-id pub-id-type="pmid">21536743</object-id>; PubMed Central PMCID: PMCPmc3092345.</mixed-citation></ref>
<ref id="ppat.1006498.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williams</surname> <given-names>LD</given-names></name>, <name name-style="western"><surname>Bansal</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sabbaj</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Heath</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers</article-title>. <source>J Virol</source>. <year>2011</year>;<volume>85</volume>(<issue>5</issue>):<fpage>2316</fpage>–<lpage>24</lpage>. Epub 2010/12/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.01476-10" xlink:type="simple">10.1128/JVI.01476-10</ext-link></comment> <object-id pub-id-type="pmid">21159862</object-id>; PubMed Central PMCID: PMCPmc3067790.</mixed-citation></ref>
<ref id="ppat.1006498.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jessen</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Faller</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Krempl</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Ehl</surname> <given-names>S</given-names></name>. <article-title>Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection</article-title>. <source>J Virol</source>. <year>2011</year>;<volume>85</volume>(<issue>19</issue>):<fpage>10135</fpage>–<lpage>43</lpage>. Epub 2011/07/29. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00816-11" xlink:type="simple">10.1128/JVI.00816-11</ext-link></comment> <object-id pub-id-type="pmid">21795345</object-id>; PubMed Central PMCID: PMCPMC3196413.</mixed-citation></ref>
<ref id="ppat.1006498.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McClelland</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Granger</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Potts</surname> <given-names>WK</given-names></name>. <article-title>Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice</article-title>. <source>Infection and Immunity</source>. <year>2003</year>;<volume>71</volume>(<issue>8</issue>):<fpage>4815</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/IAI.71.8.4815-4817.2003" xlink:type="simple">10.1128/IAI.71.8.4815-4817.2003</ext-link></comment> PMC166009. <object-id pub-id-type="pmid">12874366</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kubinak</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Stephens</surname> <given-names>WZ</given-names></name>, <name name-style="western"><surname>Soto</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Chiaro</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Gogokhia</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>MHC variation sculpts individualized microbial communities that control susceptibility to enteric infection</article-title>. <source>Nat Commun</source>. <year>2015</year>;<volume>6</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms9642" xlink:type="simple">10.1038/ncomms9642</ext-link></comment> <object-id pub-id-type="pmid">26494419</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Srikiatkhachorn</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Braciale</surname> <given-names>TJ</given-names></name>. <article-title>Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent</article-title>. <source>J Virol</source>. <year>1999</year>;<volume>73</volume>(<issue>8</issue>):<fpage>6590</fpage>–<lpage>7</lpage>. PMC112743. <object-id pub-id-type="pmid">10400756</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Swihart</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Fruth</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Messmer</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Hug</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Behin</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response</article-title>. <source>J Exp Med</source>. <year>1995</year>;<volume>181</volume>(<issue>3</issue>):<fpage>961</fpage>–<lpage>71</lpage>. Epub 1995/03/01. <object-id pub-id-type="pmid">7869054</object-id>; PubMed Central PMCID: PMCPmc2191906.</mixed-citation></ref>
<ref id="ppat.1006498.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raj</surname> <given-names>NB</given-names></name>, <name name-style="western"><surname>Cheung</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Rosztoczy</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Pitha</surname> <given-names>PM</given-names></name>. <article-title>Mouse genotype affects inducible expression of cytokine genes</article-title>. <source>J immunol</source>. <year>1992</year>;<volume>148</volume>(<issue>6</issue>):<fpage>1934</fpage>–<lpage>40</lpage>. <object-id pub-id-type="pmid">1371793</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van der Most</surname> <given-names>RG</given-names></name>, <name name-style="western"><surname>Murali-Krishna</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Lanier</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Wherry</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Puglielli</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Blattman</surname> <given-names>JN</given-names></name>, <etal>et al</etal>. <article-title>Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation</article-title>. <source>Virology</source>. <year>2003</year>;<volume>315</volume>(<issue>1</issue>):<fpage>93</fpage>–<lpage>102</lpage>. Epub 2003/11/01. <object-id pub-id-type="pmid">14592762</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barber</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Wherry</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Masopust</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Allison</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Sharpe</surname> <given-names>AH</given-names></name>, <etal>et al</etal>. <article-title>Restoring function in exhausted CD8 T cells during chronic viral infection</article-title>. <source>Nature</source>. <year>2006</year>;<volume>439</volume>(<issue>7077</issue>):<fpage>682</fpage>–<lpage>7</lpage>. Epub 2005/12/31. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature04444" xlink:type="simple">10.1038/nature04444</ext-link></comment> <object-id pub-id-type="pmid">16382236</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frebel</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Nindl</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Schuepbach</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Braunschweiler</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Richter</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Vogel</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice</article-title>. <source>J Exp Med</source>. <year>2012</year>;<volume>209</volume>(<issue>13</issue>):<fpage>2485</fpage>–<lpage>99</lpage>. Epub 2012/12/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20121015" xlink:type="simple">10.1084/jem.20121015</ext-link></comment> <object-id pub-id-type="pmid">23230000</object-id>; PubMed Central PMCID: PMCPmc3526355.</mixed-citation></ref>
<ref id="ppat.1006498.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zajac</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Blattman</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Murali-Krishna</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sourdive</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Suresh</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>JD</given-names></name>, <etal>et al</etal>. <article-title>Viral immune evasion due to persistence of activated T cells without effector function</article-title>. <source>J Exp Med</source>. <year>1998</year>;<volume>188</volume>(<issue>12</issue>):<fpage>2205</fpage>–<lpage>13</lpage>. Epub 1998/12/22. <object-id pub-id-type="pmid">9858507</object-id>; PubMed Central PMCID: PMCPmc2212420.</mixed-citation></ref>
<ref id="ppat.1006498.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blackburn</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Shin</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Haining</surname> <given-names>WN</given-names></name>, <name name-style="western"><surname>Zou</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Workman</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Polley</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection</article-title>. <source>Nat Immunol</source>. <year>2009</year>;<volume>10</volume>(<issue>1</issue>):<fpage>29</fpage>–<lpage>37</lpage>. Epub 2008/12/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ni.1679" xlink:type="simple">10.1038/ni.1679</ext-link></comment> <object-id pub-id-type="pmid">19043418</object-id>; PubMed Central PMCID: PMCPmc2605166.</mixed-citation></ref>
<ref id="ppat.1006498.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aubert</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Kamphorst</surname> <given-names>AO</given-names></name>, <name name-style="western"><surname>Sarkar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Vezys</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Ha</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Barber</surname> <given-names>DL</given-names></name>, <etal>et al</etal>. <article-title>Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection</article-title>. <source>PNAS</source>. <year>2011</year>;<volume>108</volume>(<issue>52</issue>):<fpage>21182</fpage>–<lpage>7</lpage>. Epub 2011/12/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1118450109" xlink:type="simple">10.1073/pnas.1118450109</ext-link></comment> <object-id pub-id-type="pmid">22160724</object-id>; PubMed Central PMCID: PMCPmc3248546.</mixed-citation></ref>
<ref id="ppat.1006498.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McDermott</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Varga</surname> <given-names>SM</given-names></name>. <article-title>Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think</article-title>. <source>J Immunol</source>. <year>2011</year>;<volume>187</volume>(<issue>11</issue>):<fpage>5568</fpage>–<lpage>76</lpage>. Epub 2011/11/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.1102104" xlink:type="simple">10.4049/jimmunol.1102104</ext-link></comment> <object-id pub-id-type="pmid">22043009</object-id>; PubMed Central PMCID: PMCPMC3221938.</mixed-citation></ref>
<ref id="ppat.1006498.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whitmire</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Whitton</surname> <given-names>JL</given-names></name>. <article-title>Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection</article-title>. <source>J Exp Med</source>. <year>2005</year>;<volume>201</volume>(<issue>7</issue>):<fpage>1053</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20041463" xlink:type="simple">10.1084/jem.20041463</ext-link></comment> <object-id pub-id-type="pmid">15809350</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hegazy</surname> <given-names>AN</given-names></name>, <name name-style="western"><surname>Peine</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Helmstetter</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Panse</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Fröhlich</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bergthaler</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Interferons direct Th2 cell reprogramming to generate a stable GATA-3+T-bet+ cell subset with combined Th2 and Th1 cell functions</article-title>. <source>Immunity</source>. <year>2010</year>;<volume>32</volume>(<issue>1</issue>):<fpage>116</fpage>–<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2009.12.004" xlink:type="simple">10.1016/j.immuni.2009.12.004</ext-link></comment> <object-id pub-id-type="pmid">20079668</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Elsaesser</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Sauer</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Brooks</surname> <given-names>DG</given-names></name>. <article-title>IL-21 is required to control chronic viral infection</article-title>. <source>Science</source>. <year>2009</year>;<volume>324</volume>(<issue>5934</issue>):<fpage>1569</fpage>–<lpage>72</lpage>. Epub 2009/05/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1174182" xlink:type="simple">10.1126/science.1174182</ext-link></comment> <object-id pub-id-type="pmid">19423777</object-id>; PubMed Central PMCID: PMCPmc2830017.</mixed-citation></ref>
<ref id="ppat.1006498.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frohlich</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kisielow</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Schmitz</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Freigang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Shamshiev</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Weber</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>IL-21R on T cells is critical for sustained functionality and control of chronic viral infection</article-title>. <source>Science</source>. <year>2009</year>;<volume>324</volume>(<issue>5934</issue>):<fpage>1576</fpage>–<lpage>80</lpage>. Epub 2009/05/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1172815" xlink:type="simple">10.1126/science.1172815</ext-link></comment> <object-id pub-id-type="pmid">19478140</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ou</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Moskophidis</surname> <given-names>D</given-names></name>. <article-title>Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells</article-title>. <source>J Virol</source>. <year>2001</year>;<volume>75</volume>(<issue>18</issue>):<fpage>8407</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.75.18.8407-8423.2001" xlink:type="simple">10.1128/JVI.75.18.8407-8423.2001</ext-link></comment> <object-id pub-id-type="pmid">11507186</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kamperschroer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Quinn</surname> <given-names>DG</given-names></name>. <article-title>The role of proinflammatory cytokines in wasting disease during lymphocytic choriomeningitis virus infection</article-title>. <source>J Immunol</source>. <year>2002</year>;<volume>169</volume>(<issue>1</issue>):<fpage>340</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.169.1.340" xlink:type="simple">10.4049/jimmunol.169.1.340</ext-link></comment> <object-id pub-id-type="pmid">12077263</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Quinn</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Zajac</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Frelinger</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Muller</surname> <given-names>D</given-names></name>. <article-title>Transfer of lymphocytic choriomeningitis disease in β2-microglobulin-deficient mice by CD4+ T cells</article-title>. <source>Int Immunol</source>. <year>1993</year>;<volume>5</volume>(<issue>10</issue>):<fpage>1193</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/intimm/5.10.1193" xlink:type="simple">10.1093/intimm/5.10.1193</ext-link></comment> <object-id pub-id-type="pmid">7903551</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jamieson</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Butler</surname> <given-names>LD</given-names></name>, <name name-style="western"><surname>Ahmed</surname> <given-names>R</given-names></name>. <article-title>Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells</article-title>. <source>J Virol</source>. <year>1987</year>;<volume>61</volume>(<issue>12</issue>):<fpage>3930</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">3500329</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiong</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Luscher</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Hulsey</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Robinson</surname> <given-names>HL</given-names></name>, <name name-style="western"><surname>Ostrowski</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8+ T cells with a defect in effector function that is reversible on extended interleukin-2 incubation</article-title>. <source>J Virol</source>. <year>2001</year>;<volume>75</volume>(<issue>6</issue>):<fpage>3028</fpage>–<lpage>33</lpage>. Epub 2001/02/27. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.75.6.3028-3033.2001" xlink:type="simple">10.1128/JVI.75.6.3028-3033.2001</ext-link></comment> <object-id pub-id-type="pmid">11222730</object-id>; PubMed Central PMCID: PMCPmc115931.</mixed-citation></ref>
<ref id="ppat.1006498.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lipoldova</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Demant</surname> <given-names>P</given-names></name>. <article-title>Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis</article-title>. <source>Nat Rev Genet</source>. <year>2006</year>;<volume>7</volume>(<issue>4</issue>):<fpage>294</fpage>–<lpage>305</lpage>. <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/nrg/journal/v7/n4/suppinfo/nrg1832_S1.html" xlink:type="simple">http://www.nature.com/nrg/journal/v7/n4/suppinfo/nrg1832_S1.html</ext-link>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrg1832" xlink:type="simple">10.1038/nrg1832</ext-link></comment> <object-id pub-id-type="pmid">16543933</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stark</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>McDowell</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Koenigsknecht</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Prows</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Leikauf</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Le Vine</surname> <given-names>AM</given-names></name>, <etal>et al</etal>. <article-title>Genetic susceptibility to respiratory syncytial virus infection in inbred mice</article-title>. <source>J Med Virol</source>. <year>2002</year>;<volume>67</volume>(<issue>1</issue>):<fpage>92</fpage>–<lpage>100</lpage>. Epub 2002/03/29. <object-id pub-id-type="pmid">11920822</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Toth</surname> <given-names>LA</given-names></name>. <article-title>Strain differences in the somnogenic effects of interferon inducers in mice</article-title>. <source>J Interferon Cytokine Res</source>. <year>1996</year>;<volume>16</volume>(<issue>12</issue>):<fpage>1065</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/jir.1996.16.1065" xlink:type="simple">10.1089/jir.1996.16.1065</ext-link></comment> <object-id pub-id-type="pmid">8974010</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deenick</surname> <given-names>EK</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Gatto</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Schwartzberg</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Brink</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling</article-title>. <source>Immunity</source>. <year>2010</year>;<volume>33</volume>(<issue>2</issue>):<fpage>241</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2010.07.015" xlink:type="simple">10.1016/j.immuni.2010.07.015</ext-link></comment> <object-id pub-id-type="pmid">20691615</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jordan</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Hildeman</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kappler</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Marrack</surname> <given-names>P</given-names></name>. <article-title>An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder</article-title>. <source>Blood</source>. <year>2004</year>;<volume>104</volume>(<issue>3</issue>):<fpage>735</fpage>–<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1182/blood-2003-10-3413" xlink:type="simple">10.1182/blood-2003-10-3413</ext-link></comment> <object-id pub-id-type="pmid">15069016</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Badovinac</surname> <given-names>VP</given-names></name>, <name name-style="western"><surname>Hamilton</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Harty</surname> <given-names>JT</given-names></name>. <article-title>Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice</article-title>. <source>Immunity</source>. <year>2003</year>;<volume>18</volume>(<issue>4</issue>):<fpage>463</fpage>–<lpage>74</lpage>. Epub 2003/04/23. <object-id pub-id-type="pmid">12705850</object-id>.</mixed-citation></ref>
<ref id="ppat.1006498.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Olson</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>McDermott</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Varga</surname> <given-names>SM</given-names></name>. <article-title>The initial draining lymph node primes the bulk of the CD8 T cell response and influences memory T cell trafficking after a systemic viral infection</article-title>. <source>PLoS Pathog</source>. <year>2012</year>;<volume>8</volume>(<issue>12</issue>):<fpage>e1003054</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1003054" xlink:type="simple">10.1371/journal.ppat.1003054</ext-link></comment> <object-id pub-id-type="pmid">23236277</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Battegay</surname> <given-names>M</given-names></name>. <article-title>Quantifizierung des Lympho-Choriomeningitis-Virus mit einer immunologischen Fokustechnik in 24- oder 96-Loch-Platten</article-title>. <source>ALTEX</source>. <year>1993</year>;<volume>10</volume>(<issue>1</issue>):<fpage>6</fpage>–<lpage>14</lpage>. <object-id pub-id-type="pmid">11178349</object-id></mixed-citation></ref>
<ref id="ppat.1006498.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Korns Johnson</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Homann</surname> <given-names>D</given-names></name>. <article-title>Accelerated and Improved Quantification of Lymphocytic Choriomeningitis Virus (LCMV) Titers by Flow Cytometry</article-title>. <source>PLOS ONE</source>. <year>2012</year>;<volume>7</volume>(<issue>5</issue>):<fpage>e37337</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0037337" xlink:type="simple">10.1371/journal.pone.0037337</ext-link></comment> <object-id pub-id-type="pmid">22615984</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>